![]() |
市場調查報告書
商品編碼
1351137
2030 年注射包裝市場預測 - 按產品類型、材料類型、包裝類型和地區分類的全球分析Parenteral Packaging Market Forecasts to 2030 - Global Analysis By Product Type (Vials, Pre-filled Syringes, Cartridges, Bags and Other Product Types), Material Type (Glass, Plastic and Other Material Types), Packaging Type and By Geography |
根據 Stratistics MRC 的數據,2023 年全球注射包裝市場規模為 122.4 億美元,預計到 2030 年將達到 190.3 億美元,預測期內年複合成長率為 6.5%。
腸胃外包裝是一種用於藥品和保健產品的解決方案,可讓藥物或其他液體在儲存期間直至給藥之前保持其效力或治療效果。高死亡率以及對 COVID-19 疫苗需求的增加,推動了對快速交付藥物和藥物的需求,同時又不喪失對各種慢性疾病的療效。因此,對疫苗和藥物的需求增加,保護它們免受污染的需求也增加。
根據USP(美國藥典),注射用包裝容器使用的玻璃有兩種。 I 型玻璃是硼矽酸鹽玻璃,用於中性配方。 Ⅱ型是鈉鈣玻璃,用於包裝酸性、鹼性和中性腸胃外製劑。
隨著世界主要經濟體人均衛生服務消費量的增加,人們認為全球注射包裝市場的擴大。基於抗體的免疫是一項重要的福利介入措施,可顯著改善大眾的健康。家長的擔憂與疫苗接種密切相關。例如,公共當局定期提出美國國家疫苗計劃(NVP)和2011-2020年全球疫苗行動計劃(GVAP)等免疫計劃,以根除小兒麻痺和肝炎等疾病。進一步提振注射劑捆綁市場。
研究、開發和實施先進封裝技術所需的大量初始投資是該行業面臨的最大挑戰之一。這包括設計和製造專用包裝設備和材料的成本。此外,如果小型製藥公司和新興企業無法為這些投資分配資金,它們在市場上成功競爭的能力可能會受到限制。
注射包裝公司有機會與製藥商合作,開發尖端的藥物傳輸系統,例如穿戴式注射器、自動注射器和帶有感測器的智慧包裝。此外,這些技術進步提高了患者的舒適度、依從性和依從性,並為創意包裝概念開闢了新市場。
注射劑包裝市場競爭激烈,許多企業爭奪市場佔有率。由於製造商與製藥公司爭奪合約,這種激烈的競爭往往會帶來價格壓力。因此,企業可能會發現很難在保持高標準的同時將資源分配給研發和創新,這可能會導致報酬率下降。
注射劑包裝市場在許多方面都受到了 COVID-19 大流行的嚴重影響。隨著製藥公司爭先恐後地開發和分銷 COVID-19 疫苗和治療方法,需求最初有所增加,尤其是對疫苗和基本藥物的包裝用品和解決方案的需求。此外,需求的增加給供應鏈帶來了壓力,導致一些包裝零件出現短期短缺和價格變化。疫情也造成物流和製造中斷,導致生產和分銷放緩。
預計預充式注射器細分市場將在整個預測期內佔據最大的市場佔有率。製藥公司更喜歡預充式注射器,因為它們易於使用且給藥準確,使其成為疫苗、胰島素和生物製劑等各種注射藥物的良好選擇。此外,這些注射器已經含有單一劑量的藥物,減少了污染或給藥錯誤的機會。此外,它適用於快速發展的生物技術領域,因此經常用於新生物療法的給藥。
塑膠產業預計將呈現良好的成長動能。聚丙烯和環烯烴聚合物 (COP) 等塑膠材料因其柔韌性、重量輕和比玻璃更低的製造成本而普及。塑膠瓶和容器經常用於注射劑包裝,特別是口服液和一些注射。此外,預充式塑膠注射器和輸液袋等塑膠包裝技術的發展是創造性和複雜的塑膠包裝解決方案的例子。
預計北美在預測期內將佔據最大的市場佔有率。該地區成熟的製藥和生物技術部門是其佔據市場主導地位的主要原因,從而推動了對複雜且合規的包裝解決方案的需求。此外,北美對藥物安全、以患者為中心的包裝和醫療保健提供系統創新的關注鞏固了其在全球注射劑包裝市場的領先地位。
預計歐洲將在預期期間錄得強勁成長。歐洲強勁的製藥和生物技術行業以及嚴格的法規環境推動了一流注射劑包裝解決方案的持續創新和採用。此外,歐洲市場的特點是高度重視環境永續性,鼓勵創造和採用環保包裝產品和程序。對腸胃外藥物(包括先進包裝形式)的需求不斷成長也是由於歐洲高齡化和慢性病患病不斷上升所致。
According to Stratistics MRC, the Global Parenteral Packaging Market is accounted for $12.24 billion in 2023 and is expected to reach $19.03 billion by 2030 growing at a CAGR of 6.5% during the forecast period. Parenteral packaging is a type of solution used in pharmaceuticals and healthcare products that enables the medication or other fluid to maintain its potency and therapeutic effectiveness throughout the shelf life or until the drug is administered. The high mortality rate has fueled the demand for quick delivery of medications and drugs without loss of potency because of various chronic diseases, along with the rising demand for COVID-19 vaccines. The result has been a rise in demand for vaccines and medications, as well as the requirement to safeguard drugs from contamination.
According to USP (United States Pharmacopeia) there are two types of glass used for parenteral packaging containers. Type I glass is a borosilicate glass and used for neutral preparation. Type II is soda lime glass and is used for packaging acidic alkaline and neutral parenteral preparations.
The expansion of the global market for parenteral packaging is taken into account with the rising per capita consumption of medical services in the world's major economies. Antibody-based vaccinations are a significant well-being intervention that significantly improves the health of the general populace. Parenterally administered interest is closely related to immunization. For instance, vaccination programs like the National Vaccine Plan (NVP) by the U.S. and the Global Vaccine Action Plan (GVAP) 2011-2020, which are presented by the public authority at regular intervals to eradicate diseases like polio and hepatitis, are relying on them to further fuel the parenteral bundling market.
The sizeable initial investment needed for research, development, and implementation of advanced packaging technologies is one of the industry's biggest challenges. Included in this are the expenses incurred in the design and production of specialized packaging equipment and materials. Moreover, the inability of smaller pharmaceutical firms and startups to allocate funds for these investments may limit their ability to successfully compete in the market.
Parenteral packaging businesses have opportunities to work with pharmaceutical manufacturers as a result of the development of cutting-edge drug delivery systems like wearable injectors, auto-injectors, and smart packaging with sensors. Furthermore, these advancements in technology increase patient comfort, adherence, and compliance, opening up new markets for creative packaging ideas.
Intense competition is present in the parenteral packaging market, where many businesses are vying for market share. Price pressure is frequently a result of this fierce competition as manufacturers compete for contracts with pharmaceutical firms. As a result, companies may find it difficult to allocate resources for R&D and innovation while maintaining high standards, and as a result, profit margins may decrease.
The parenteral packaging market was significantly impacted by the COVID-19 pandemic in numerous ways. As pharmaceutical companies raced to develop and distribute COVID-19 vaccines and treatments, it initially resulted in increased demand for packaging supplies and solutions, particularly for vaccines and necessary medications. Moreover, this increase in demand put pressure on the supply chain, leading to brief shortages and changes in price for some packaging parts. The pandemic also caused logistical and manufacturing disruptions, which delayed production and distribution.
The pre-filled syringes segment is predicted to hold the largest market share throughout the forecast period. Pharmaceutical companies prefer pre-filled syringes because of how easy they are to use and how precisely they deliver dosages, which makes them a good option for a variety of injectable medicines like vaccines, insulin, and biologics. Moreover, these syringes already contain one dose of the medication, lowering the possibility of contamination and dosage mistakes. Additionally, they are also frequently used in the administration of novel biologic therapies because they are well suited for use in the rapidly developing field of biotechnology.
The plastic segment is estimated to witness lucrative growth. Due to their adaptability, light weight, and lower production costs compared to glass, plastic materials, such as polypropylene and cyclic olefin polymers (COP), have become more popular. Parenteral packaging frequently uses plastic vials and containers, particularly for oral liquids and some injectable drug formulations. Additionally, developments in plastic packaging technology, like pre-filled plastic syringes and infusion bags, are examples of creative and sophisticated plastic packaging solutions.
North America is expected to witness the largest market share during the forecast period. The established pharmaceutical and biotechnology sectors in this area are largely responsible for the dominance of this market, which in turn drives demand for sophisticated and compliant packaging solutions. Additionally, its position as the top region in the global parenteral packaging market is cemented by North America's emphasis on drug safety, patient-centric packaging, and innovations in healthcare delivery systems.
Over the anticipated period, Europe is expected to register significant growth. The robust pharmaceutical and biotechnology industries in Europe, as well as its strict regulatory environment, encourage ongoing innovation and the adoption of top-notch parenteral packaging solutions. Moreover, the European market is distinguished by a strong focus on environmental sustainability, which has prompted the creation and adoption of eco-friendly packaging products and procedures. A growing demand for parenteral medications, including those in advanced packaging formats, has also been caused by Europe's aging population and an increase in the prevalence of chronic diseases.
Some of the key players in Parenteral Packaging market include: Nipro Corporation, Catalent, Inc, Sio2 Materials Science, Schott AG, Gerresheimer AG , Baxter International Inc., Dickinson and Company, Stevanato Group S.p.A., Corning Inc., UDG Healthcare plc, Becton, West Pharmaceutical Services, Inc. , UFP Technologies, Inc. and Terumo Corporation.
In June 30, 2021, SCHOTT AG announces the inauguration of its new tube factory in Jinyun, China. The new facility will help increase production for a pharmaceutical glass tubing company used to store and package life-saving medicines.
In May 19, 2020, Sharp, a subsidiary of UDG Healthcare plc, announced that it has acquired a 160,000-square-foot pharmaceutical packaging facility from Quality Packaging Specialists International, LLC, located in Macunji, Pennsylvania, USA.